Company Filing History:
Years Active: 2023-2025
Title: Innovator Spotlight: Kelsey Sivick Gauthier
Introduction
Kelsey Sivick Gauthier is a notable inventor based in Hayward, California. With a strong focus on biotechnology, she has made significant strides in the field, particularly through her work on innovative antibodies that can play a crucial role in cancer treatment and infectious diseases.
Latest Patents
Kelsey Sivick Gauthier holds one patent titled "Antibodies to TIGIT." This patent details antibodies that specifically bind to TIGIT, allowing for substantial activation of T cells and natural killer cells. By inhibiting the binding of TIGIT to CD155, these antibodies have promising applications in treating various medical conditions, including cancer and infectious diseases.
Career Highlights
Kelsey is currently associated with Arcus Biosciences, Inc., a company dedicated to advancing cancer therapies. Her work at Arcus is characterized by a commitment to innovation and excellence, contributing to the development of groundbreaking treatments in the biotechnology field.
Collaborations
In her professional journey, Kelsey has collaborated with talented colleagues, including Nigel Pelham Clinton Walker and Xiaoning Zhao. These partnerships reflect her ability to work effectively in a team-oriented environment, fostering creativity and innovation within her field.
Conclusion
Kelsey Sivick Gauthier's contributions to the world of biotechnology, particularly with her patented antibodies, underscore the importance of innovation in tackling significant health challenges. Her work at Arcus Biosciences, Inc. and collaboration with esteemed colleagues further exemplify her dedication to advancing medical science and improving patient outcomes.